T he right ventricular outflow tract (RVOT) is the main origin of arrhythmias in the Brugada syndrome.
T he right ventricular outflow tract (RVOT) is the main origin of arrhythmias in the Brugada syndrome. 1 The mechanism underlying arrhythmias in Brugada syndrome is debated but most likely involves conduction delay or block in the presence of subtle structural discontinuities. 2 This arrhythmogenic substrate is modulated by variations or mutations in ion channels and other genes. 3 The electrocardiographic signs and arrhythmias often only become evident after application of sodium channel blockers. 4 Why arrhythmias in patients with Brugada syndrome preferentially originate in the RVOT is unclear.
During development, the RVOT forms from the embryonic outflow tract. 5 The embryonic outflow tract is a slowly conducting structure with low expression levels of connexin43, connexin40, and of the cardiac sodium channel protein α subunit (Scn5a). 6, 7 Low expression of Scn5a and connexin43 reduces the safety of propagation, also known as conduction reserve, and increases the susceptibility for arrhythmias. 8 We hypothesize that the adult RVOT myocardium retains aspects of this embryonic outflow tract phenotype and that these embryonic aspects contribute to lower conduction reserve in the RVOT.
We investigated the expression pattern of genes associated with the embryonic outflow tract phenotype and with conduction in the mouse RVOT, in relation to conduction velocity, during development and in the adult heart. Furthermore, we investigated the functional consequences of reduced sodium current on RVOT conduction by pharmacological sodium channel blockade and in a mouse model with a human cardiac sodium channel mutation associated with the Brugada syndrome.
Methods
The investigation conforms to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996) and the European Commission Directive 2010/63/EU and was approved by the institutional review board (Academic Medical Center). An expanded Methods section is available in the Online Data Supplement.
Results

Working Myocardial Gene Program in the RVOT Is Established Just Before Birth
The embryonic outflow tract is a slowly conducting structure marked by the expression of T-box2 (Tbx2), and absence of gap junction protein, α1 (Gja1) and hairy/enhancer-of-split related with YRPW motif 2 (Hey2). 6, 9 To investigate whether this embryonic signature is maintained in the RVOT, we investigated the expression patterns of these markers in the early fetal (E14.5) and late fetal (E17.5) mouse hearts by in situ hybridization. At E14.5, the expression of Gja1 was absent from the RVOT myocardium but present in the right ventricle (RV; Figure 1 ). This pattern was similar to that of Hey2. The expression of Tbx2 was maintained in the RVOT, in a pattern complementary to Gja1 and Hey2 (arrows in Figure 1A ). At stage E17.5, Gja1 and Hey2 were still absent from the RVOT region that had relatively decreased in size compared with the ventricle. In contrast to stage E14.5, however, the expression of Tbx2 was absent from the RVOT myocardium marked by troponin I, cardiac (Tnni3; Figure 1B) . Scn5a, unlike Gja1, was already expressed in the outflow tract at E12.5 (Online Figure IA ) and remained expressed in the RVOT throughout later stages. These data indicate that the fetal RVOT, at least in part, retains the signature of the embryonic outflow tract. The absence of Tbx2 expression just before birth (E17.5) suggests that the myocardium in the RVOT has acquired aspects of the ventricular working myocardial phenotype.
In the adult heart, the expression of Gja1 was lower in the subepicardial region of the RVOT myocardium compared with the right or left ventricular myocardium ( Figure 1C ; Online Figure IB ), and the expression of Tbx2 and Hey2 was absent from the ventricular myocardium. We measured Gja1 and Scn5a mRNA levels by quantitative reverse transcription polymerase chain reaction in the entire adult RVOT. For this purpose, the RVOT was defined as the smooth walled myocardium located at the base of the RV below the pulmonary valves ( Figure 2A ). Tnni3 was used as a marker of myocardial tissue and was not quantitatively different between the RVOT and the RV and left ventricle (LV; data not shown). The expression levels of both Gja1 and Scn5a were significantly lower in the RVOT than in the RV and LV, but not between LV and RV ( Figure 2B and 2C). Next we measured the protein levels of connexin43 and NAV1.5 by Western blot, and found that they were lower in the RVOT than in the RV ( Figure 2D and 2E ). These data demonstrate that, also in the adult RVOT, aspects of the embryonic program are maintained. The samples likely contained a mixture of both the subendo-and subepicardium of the RVOT and, therefore, the quantifications probably represent an underestimation of the differences. 
Slow Conduction in the Fetal Outflow Tract
In the fetal heart (E14.5), conduction was slower in RVOT than in the RV (Figure 3) , consistent with the absence of Gja1 in the RVOT. Because Tbx2 represses nonworking myocardium genes, including Gja1, 10 we studied hearts from homozygous Tbx2 mutant mice. The RVOT of these mice was normal and Gja1 expression was not different from wild-type mice ( Figure 3A) . Furthermore, conduction in the RVOT of wildtype mice and Tbx2 mutants was not different ( Figure 3B ). These data imply that RVOT conduction characteristics are not A, The part of the heart that was defined as RVOT. The bar graphs in B and C show, respectively, the expression levels (quantitative polymerase chain reaction, corrected for Hprt and Tnni3) of Gja1 and Scn5a in the RVOT and right and left ventricle (RV and LV; n=5). D and E, The protein levels of connexin43 (CX43; n=6) and NAV1.5 (n=3) in the RVOT and RV and LV. Calnexin was used as a loading control. AO indicates aorta; Scn5a, sodium channel, voltage-gated, type V, α-subunit; and TP, truncus pulmonalis. RVOT; n=3) . B, A reconstructed activation pattern of the RV and the RVOT in an E14.5 wild-type heart. The straight lines connect the 2 pairs of pixels that were used for the calculation of conduction velocity. The bar graph in C shows the average conduction velocity in the RV and RVOT. D, The activation patterns during stimulation at a site in the left ventricle (LV), RV, and RVOT in the adult heart. The bar graph in E shows the average longitudinal and transversal conduction velocity in the adult RV and LV and the RVOT (n=3). In the RVOT, longitudinal conduction velocity could not be measured. AO indicates aorta; and TP, truncus pulmonalis. regulated by Tbx2. Tbx3, the related transcriptional regulator and functional homologue of Tbx2, is not likely to compensate for loss of Tbx2, as it is not expressed in the myocardial component of the outflow tract or RVOT during development or in the adult (Online Figure IB) . 10 
Slow Conduction Is Not Maintained in the Adult RVOT
The transversal conduction velocity recorded after pacing in the adult RVOT was not slower than in the RV or LV (Figure 3D and 3E). We did not quantify longitudinal conduction velocity in the RVOT because the typically anisotropic activation pattern after stimulation was not present. We argued that lower levels of GJA1 and NAV1.5 in the RVOT would not lead to conduction slowing because the safety for conduction is very high because of the nonlinear relation between electric coupling and conduction velocity, consistent with the observation that in healthy humans no arrhythmias originate in the RVOT.
11-13 However, we hypothesized that an additional reduction of sodium current would be required to lead to further reduction in safety of conduction and thereby unmask the intrinsic regional difference in conduction reserve. For that reason, we measured conduction velocity in the RVOT and RV before and after administration of the sodium channel blocker ajmaline ( Figure 4A ). Ajmaline reduced the transversal conduction velocity more in the RVOT than in the RV (Figure 4B and 4C) .
Sodium Channel Dysfunction Results in Conduction Slowing in the RVOT
We then measured ventricular conduction in mice with a 1798InsD mutation in Scn5a, the mouse equivalent of the human 1795InsD mutation found in patients with Brugada syndrome.
14 During sinus rhythm, crowding of isochrones indicated that conduction was delayed in the RV and RVOT of Scn5a 1798insD/+ mice compared with wild-type littermates (Online Figure II) . We subsequently measured conduction velocity after stimulation from the RV and RVOT. In Scn5a 1798insD/+ mice, conduction velocity was lower than in wild-type mice in both the RV and RVOT ( Figure 4D ). Conduction slowing was significantly more pronounced in the RVOT than in the RV of Scn5a 1798insD/+ mice ( Figure 4E and 4F). Thus, reduced sodium channel function unmasked slow conduction in the adult RVOT, indicating maintenance of the embryonic gene program responsible for slow conduction.
We have recently proposed a unifying mechanism for arrhythmogenesis in Brugada syndrome patients 2 involving subtle structural discontinuities in the RVOT myocardium. This hypothesis does not offer an explanation for the preferential location of these abnormalities in the RVOT because these structural abnormalities and a mutation are also present in the LV and RV. 15 Our data indicate that in the RVOT the expression of Gja1 and Scn5a is persistently lower than in the RV, which offers an explanation for the preference of conduction delays or block in the RVOT, and not the RV, of Brugada syndrome patients, especially after pharmacological or genetically reduced sodium channel function.
Limitations
In this study, we used mouse hearts which are electrophysiologically different from human hearts. This may complicate extrapolation from our findings in mice to man. Furthermore, we determined changes in transcript and protein abundance which do not predict with certainty whether there will be changes in the presence of functional channels. However, our functional data support the notion that differences in expression between the RVOT and the RV underlie the electrophysiological differences between these components. A genetic rescue experiment to remove the electrophysiological differences between the RVOT and RV could further support our hypothesis.
Conclusions
We demonstrate that the Tbx2-positive, Gja1-negative myocardial gene program and the slow-conducting phenotype of the embryonic outflow tract myocardium are maintained in the RVOT until birth. In the adult heart, lower expression levels of Gja1 and Scn5a are still observed in the RVOT. We demonstrate that this is associated with less conduction reserve in the RVOT than in the RV, resulting in more pronounced conduction slowing in the RVOT than in the RV when sodium current is decreased. Our data provide an explanation why conduction delay occurs preferentially in the RVOT, as is observed in patients with Brugada syndrome.
